The trademark application HEVDUA was filed by Theravance Biopharma Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on August 13, 2020, and it was registered by office on November 23, 2020 without any oppositions.
It was designated 'Basic Application' for International Application 1578160 at the World Intellectual Property Organization (WIPO).
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 8, 2020. Change of name and address of the trademark registration was recorded on May 23, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals, medical and veterinary preparations
Diagnostic preparations and materials
Pharmaceuticals and natural remedies
Pharmaceutical products for treatment of human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system
Pharmaceutical preparations for the treatment of cancer and pain
Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders
Pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders
Pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure
Pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents
Pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders
Pharmaceutical preparations and substances for the prevention and treatment of dizziness and lightheadedness
Pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine
Pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely anti-infectives.